Donor-specific tolerance in a murine model: The result of extra-thymic T cell deletion?

Transplant Immunology

Volumn 11, Issue 3-4, 2003, Pages 375-384

  Van Pel, Melissa ^a   Van Breugel, Danielle W J G ^a   Van Wijk, Margot ^a   Luypen, Sacco ^a   Vingerhoed, Jose ^b   Roholl, Paul J M ^a   Boog, Claire J P ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

In vivo animal models; Tolerance suppression; Transplantation

Indexed keywords

ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL SELECTION; CHIMERA; CLONING; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DONOR; EXPERIMENTAL MODEL; GENE DELETION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KINETICS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; T LYMPHOCYTE; THYMECTOMY; THYMUS;

ANIMALS; BONE MARROW TRANSPLANTATION; CHIMERA; CLONAL DELETION; IMMUNE TOLERANCE; INTESTINE, SMALL; MALE; MICE; MICE, INBRED BALB C; SKIN TRANSPLANTATION; T-LYMPHOCYTES; THYMECTOMY; THYMUS GLAND; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0141853298     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00157-0     Document Type: Article

References (43)

1. Schwartz RH. Models of T cell anergy: Is there a common molecular mechanism? J Exp Med 1996;184(1):1-8.
2. Quill H. Anergy as a mechanism of peripheral T cell tolerance. J Immunol 1996;156(4):1325-1327.
3. Kamradt T, Mitchison NA. Tolerance and autoimmunity. N Engl J Med 2001;344(9):655-664.
4. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 1998;280(5361):243-248.
5. Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Nomoto K. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion. J Immunol 1990;145(5):1303-1310.
6. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory t cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166(6):3789-3796.
7. Colson YL, Lange J, Fowler K, Ildstad ST. Mechanism for cotolerance in nonlethally conditioned mixed chimeras: Negative selection of the Vbeta T-cell receptor repertoire by both host and donor bone marrow-derived cells. Blood 1996;88(12):4601-4610.
8. Manilay JO, Pearson DA, Sergio JJ, Swenson KG, Sykes M. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation 1998;66(1):96-102.
9. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994;153(3):1087-1098.
10. Wekerle T, Sayegh MH, Hill J, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998;187(12):2037-2044.
11. Yoshikai Y, Ogimoto M, Matsuzaki G, Nomoto K. Bone marrow-derived cells are essential for intrathymic deletion of self-reactive T cells in both the host- and donor-derived thymocytes of fully allogeneic bone marrow chimeras. J Immunol 1990;145(2):505-509.
12. Tomita Y, Nishimura Y, Harada N, et al. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion. J Immunol 1990;145(12):4026-4036.
13. Ramsdell F, Fowlkes BJ. Clonal deletion versus clonal anergy: The role of the thymus in inducing self tolerance. Science 1990;248(4961):1342-1348.
14. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953;172:603-606.
15. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984;307(5947):168-170.
16. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 1989;169(2):493-502.
17. De Vries-Van Der Zwan A, Besseling AC, Kievits F, Van Twuyver E, De Waal LP. Anti-CD3 treatment facilitates engraftment of full H-2-disparate donor bone marrow cells and subsequent skin allograft tolerance. Transplantation 1994;58(5):610-617.
18. De Vries-Van Der Zwan A, Besseling AC, Van Der Pol MA, De Waal LP, Boog CJ. Specific tolerance induction and organ transplantation. Leuk Lymphoma 1998;31(1-2):131-142.
19. Van Pel M, Vingerhoed J, De Vries-Van Der Zwan A, Van Der Pol MA, Boog CJ. Mechanisms of donor-specific tolerance in a skin transplantation model. Transplant Proc 2001;33(1-2):152-153.
20. Leclercq G, Plum J. Thymic and extrathymic T cell development. Leukemia 1996;10(12):1853-1859.
21. Surh CD, Ernst B, Lee DS, Dummer W, LeRoy E. Role of self-major histocompatibility complex/peptide ligands in selection and maintenance of a diverse T cell repertoire. Immunol Res 2000:21(2-3):331-339.
22. Khan A, Tomita Y, Sykes M. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 1996;62(3):380-387.
23. Salaun J, Bandeira A, Khazaal I, et al. Transplantation tolerance is unrelated to superantigen-dependent deletion and anergy. Proc Natl Acad Sci USA 1992;89(21):10420-10424.
24. Colson YL, Abou El-Ezz AY, Gaines BA, Ildstad ST. Positive and negative selection of alphabetaTCR+ T cells in thymectomized adult radiation bone marrow chimeras. Transplantation 1999;68(3):403-410.
25. Korngold B, Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med 1978;148(6):1687-1698.
26. Scully R, Cobbold SP, Mellor AL, Wissing M, Arnold B, Waldmann H. A role for Th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection. Eur J Immunol 1997;27(7):1663-1670.
27. De Vries-Van Der Zwan A, Besseling AC, De Waal LP, Boog CJ. Specific tolerance induction and transplantation: A single-day protocol. Blood 1997;89(7):2596-2601.
28. Goss JA, Pyo R, Flye MW, Connolly JM, Hansen TH. Major histocompatibility complex-specific prolongation of murine skin and cardiac allograft survival after in vivo depletion of V beta+ T cells. J Exp Med 1993;177(1):35-44.
29. Rodewald HR, Koszinowski UH, Eichmann K, Melchers I. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld- restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus. J Immunol 1989;143(12):4238-4243.
30. Rubocki RJ, Hansen TH, Lee DR. Molecular studies of murine mutant BALB/c-H-2dm2 define a deletion of several class I genes including the entire H-2Ld gene. Proc Natl Acad Sci USA 1986;83(24):9606-9610.
31. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 1987;84(5):1374-1378.
32. Ferran C, Sheehan K, Dy M, et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation. Eur J Immunol 1990;20(3):509-515.
33. Adkins B, Mueller C, Okada CY, Reichert RA, Weissman IL, Spangrude GJ. Early events in T-cell maturation. Annu Rev Immunol 1987;5325-5365.
34. Madrigal-Estebas L, McManus R, Byrne B, et al. Human small intestinal epithelial cells secrete interleukin-7 and differentially express two different interleukin-7 mRNA Transcripts: Implications for extrathymic T-cell differentiation. Hum Immunol 1997;58(2):83-90.
35. Mosley RL, Klein JR. Peripheral engraftment of fetal intestine into athymic mice sponsors T cell development: Direct evidence for thymopoietic function of murine small intestine. J Exp Med 1992;176(5):1365-1373.
36. Rocha B, Guy-Grand D, Vassalli P. Extrathymic T cell differentiation. Curr Opin Immunol 1995;7(2):235-242.
37. Imhof BA, Dunon D, Courtois D, Luhtala M, Vainio O. Intestinal CD8 alpha alpha and CD8 alpha beta intraepithelial lymphocytes are thymus derived and exhibit subtle differences in TCR beta repertoires. J Immunol 2000;165(12):6716-6722.
38. Dejbakhsh-Jones S, Garcia-Ojeda ME, Chatterjea-Matthes D, Zeng D, Strober S. Clonable progenitors committed to the T lymphocyte lineage in the mouse bone marrow; Use of an extrathymic pathway. Proc Natl Acad Sci USA 2001;98(13):7455-7460.
39. Bertolino P, Trescol-Biemont MC, Thomas J, et al. Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol 1999;11(8):1225-1238.
40. Poussier P, Julius M. Thymus independent T cell development and selection in the intestinal epithelium. Annu Rev Immunol 1994;12521-12553.
41. Lefrancois L, Puddington L. Extrathymic intestinal T-cell development: Virtual reality? Immunol Today 1995;16(1):16-21.
42. Beagley KW, Husband AJ. Intraepithelial lymphocytes: Origins, distribution, and function. Crit Rev Immunol 1998;18(3):237-254.
43. Maurice MM, Gould DS, Carroll J, Vugmeyster Y, Ploegh HL. Positive selection of an MHC class-I restricted TCR in the absence of classical MHC class I molecules. Proc Natl Acad Sci USA 2001;98(13):7437-7442.